Literature DB >> 26397748

Simultaneous determinations of 17 marker compounds in Xiao-Chai-Hu-Tang by LC-MS/MS: Application to its pharmacokinetic studies in mice.

Rongjin Sun1, Min Zeng2, Ting Du2, Li Li1, Guangyi Yang2, Ming Hu1, Song Gao3.   

Abstract

The purpose of this study is to develop and validate an UPLC-MS/MS method to quantify different marker compounds from Xiao-Chai-Hu-Tang (XCHT, a Chinese traditional herbal) in biological samples and apply the method to pharmacokinetic study. A Waters BEH C18 UPLC column was used with acetonitrile/0.1% formic acid mobile phases. The mass analysis was performed in a triple quadrupole mass spectrometer using multiple reaction monitoring (MRM) with positive scan mode. A one-step protein precipitation by methanol was used to extract the analytes from blood. Seventeen commercially available compounds from the different compositing herbals were selected as markers. The results revealed that all of the calibration curves showed good linear regression (r(2)>0.9918). The intra-day and inter-day precisions (RSD) of all of these markers at three different levels were less than 15.0% and the bias of the accuracies ranged from -13.5% to 16.6%.The extraction recoveries of all of these 17 markers were from 70.8% to 113.7% and the matrix effects ranged from 71.8% to 114.8%. The stabilities of these compounds in blood were evaluated by analyzing three replicates of QC samples at three different concentrations following storage at 25°C for 6h, 4°C for 24h, and -80°C for 30 days. All the samples displayed 85-115% precision and accuracy after various stability tests. The validated method was successfully applied to pharmacokinetic study in A/J mouse with oral administration of XCHT. All of these markers were detected and the pharmacokinetic parameters of 8 compounds were able to be calculated. This method is sensitive and reproducible that can be used for XCHT's in vivo study.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Pharmacokinetics; UPLC–MS/MS; Xiao–Chai–Hu–Tang

Mesh:

Substances:

Year:  2015        PMID: 26397748      PMCID: PMC4608253          DOI: 10.1016/j.jchromb.2015.09.004

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  29 in total

1.  Comparative pharmacokinetics of baicalin and wogonoside by liquid chromatography-mass spectrometry after oral administration of Xiaochaihu Tang and Radix scutellariae extract to rats.

Authors:  Zhenyu Zhu; Liang Zhao; Xiaofan Liu; Jun Chen; Hai Zhang; Guoqing Zhang; Yifeng Chai
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-06-25       Impact factor: 3.205

2.  [Effects of long term administration of Shakuyaku-kanzo-To and Shosaiko-To on serum potassium levels].

Authors:  Masato Homma; Miya Ishihara; Wen Qian; Yukinao Kohda
Journal:  Yakugaku Zasshi       Date:  2006-10       Impact factor: 0.302

3.  Acute hepatitis induced by Chinese hepatoprotective herb, xiao-chai-hu-tang.

Authors:  Li-Ming Hsu; Yi-Shin Huang; Shyh-Haw Tsay; Full-Young Chang; Shou-Dong Lee
Journal:  J Chin Med Assoc       Date:  2006-02       Impact factor: 2.743

4.  Sho-saiko-to (Xiao-Chai-Hu-Tang) and crude saikosaponins inhibit hepatitis B virus in a stable HBV-producing cell line.

Authors:  Jung-San Chang; Kuo-Chih Wang; Hong-Wen Liu; Mei-Chun Chen; Lien-Chai Chiang; Chun-Ching Lin
Journal:  Am J Chin Med       Date:  2007       Impact factor: 4.667

5.  A Japanese herbal medicine, Sho-saiko-to, prevents gut ischemia/reperfusion-induced hepatic microvascular dysfunction in rats.

Authors:  Y Horie; M Kajihara; Y Yamagishi; H Kimura; H Tamai; S Kato; H Ishii
Journal:  J Gastroenterol Hepatol       Date:  2001-11       Impact factor: 4.029

6.  Effects of a blended Chinese medicine, xiao-chai-hu-tang, on Lewis lung carcinoma growth and inhibition of lung metastasis, with special reference to macrophage activation.

Authors:  H Ito; K Shimura
Journal:  Jpn J Pharmacol       Date:  1986-07

7.  Effects of TJ-9 Sho-saiko-to (kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis.

Authors:  S Kakumu; K Yoshioka; T Wakita; T Ishikawa
Journal:  Int J Immunopharmacol       Date:  1991

8.  Regulation of hepatic macrophage function by oral administration of xiao-chai-hu-tang (sho-saiko-to, TJ-9) in rats.

Authors:  K Fujiwara; S Mochida; S Nagoshi; O Iijima; Y Matsuzaki; S Takeda; M Aburada
Journal:  J Ethnopharmacol       Date:  1995-05       Impact factor: 4.360

9.  Renal protective effect of xiao-chai-hu-tang on diabetic nephropathy of type 1-diabetic mice.

Authors:  Chun-Ching Lin; Liang-Tzung Lin; Ming-Hong Yen; Juei-Tang Cheng; Chung-Hsi Hsing; Ching-Hua Yeh
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-07       Impact factor: 2.629

Review 10.  Separation and isolation methods for analysis of the active principles of Sho-saiko-to (SST) oriental medicine.

Authors:  Nobuhiro Ohtake; Yoichiro Nakai; Masahiro Yamamoto; Iwao Sakakibara; Shuichi Takeda; Sakae Amagaya; Masaki Aburada
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2004-12-05       Impact factor: 3.205

View more
  2 in total

1.  Anticancer 20(R)-dammarane-3β,12β,20,25-tetrol-loaded polymeric micelles: Preparation, quantification and pharmacokinetics.

Authors:  Junxian Yu; Zhe Li; Wei Wang; Yang Zhang; Dandan Li; Yi Liu; Su Shen; Ruiwen Zhang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2016-04-01       Impact factor: 3.205

2.  Chrysosplenetin inhibits artemisinin efflux in P-gp-over-expressing Caco-2 cells and reverses P-gp/MDR1 mRNA up-regulated expression induced by artemisinin in mouse small intestine.

Authors:  Liping Ma; Shijie Wei; Bei Yang; Wei Ma; Xiuli Wu; Hongyan Ji; Hong Sui; Jing Chen
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.